Association of DNA damage response (DDR) gene mutations (mts) and response to neoadjuvant cisplatin-based chemotherapy (chemo) in muscle-invasive bladder cancer (MIBC) patients (pts) enrolled onto SWOG S1314.

被引：0
|
作者：
Iyer, Gopa
Tangen, Catherine
Sarfaty, Michal
Regazzi, Ashley Marie
Lee, I-Ling C.
Choi, Woonyoung
Dinney, Colin P. N.
Flaig, Thomas W.
Thompson, Ian M.
McConkey, David James
Rosenberg, Jonathan E.
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY USA
[2] Fred Hutchinson Canc Res Ctr, Seattle, WA USA
[3] Davidoff Canc Ctr, Rabin Med Ctr, Petah Tiqwa, Israel
[4] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[5] Johns Hopkins, Johns Hopkins Greenberg Bladder Can Inst, Dept Urol, Baltimore, MD USA
[6] Univ Colorado, Canc Ctr, Aurora, CO USA
[7] Childrens Hosp San Antonio, San Antonio, TX USA
[8] Johns Hopkins Greenberg Bladder Canc Inst, Baltimore, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4522
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Cell-free DNA methylation as a predictive biomarker of response to neoadjuvant chemotherapy for patients with muscle-invasive bladder cancer in SWOG S1314.
    Lu, Yi-Tsung
    Plets, Melissa
    Morrison, Gareth
    Cunha, Alexander T.
    Cen, Steven Y.
    Rhie, Suhn K.
    Siegmund, Kimberly
    Daneshmand, Siamak
    Quinn, David I.
    Meeks, Joshua J.
    Lerner, Seth P.
    Petrylak, Daniel P.
    McConkey, David James
    Flaig, Thomas W.
    Thompson, Ian M.
    Goldkorn, Amir
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [2] Cisplatin-based neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer (MIBC) in patients (pts) with impaired renal function.
    Koshkin, Vadim S.
    Barata, Pedro C.
    Zahoor, Haris
    Rybicki, Lisa A.
    Almassi, Nima
    Redden, Alicia M.
    Fergany, Amr Farouk
    Kaouk, Jihad
    Haber, Georges-Pascal
    Stephenson, Andrew J.
    Martin, Allison
    Allman, Kimberly D.
    Beach, Jennifer
    Ornstein, Moshe Chaim
    Gilligan, Timothy D.
    Garcia, Jorge A.
    Rini, Brian I.
    Grivas, Petros
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [3] The impact of smoking on pathologic response to neoadjuvant cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer
    Philip H. Kim
    Matthew Kent
    Philip Zhao
    John P. Sfakianos
    Dean F. Bajorin
    Bernard H. Bochner
    Guido Dalbagni
    World Journal of Urology, 2014, 32 : 453 - 459
  • [4] The impact of smoking on pathologic response to neoadjuvant cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer
    Kim, Philip H.
    Kent, Matthew
    Zhao, Philip
    Sfakianos, John P.
    Bajorin, Dean F.
    Bochner, Bernard H.
    Dalbagni, Guido
    WORLD JOURNAL OF UROLOGY, 2014, 32 (02) : 453 - 459
  • [5] DNA Damage Response Alterations Predict for Neoadjuvant Chemotherapy Sensitivity in Muscle-Invasive Bladder Cancer: A Correlative Analysis of the SWOG S1314 Trial
    Iyer, Gopa
    Tangen, Catherine M.
    Sarfaty, Michal
    Regazzi, Ashley M.
    Lee, I-Ling
    Fong, Megan
    Choi, Woonyoung
    Dinney, Colin P. N.
    Flaig, Thomas W.
    Thompson Jr, Ian M.
    Lerner, Seth P.
    McConkey, David J.
    Rosenberg, Jonathan E.
    JCO PRECISION ONCOLOGY, 2024, 8
  • [6] Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer
    Plimack, Elizabeth R.
    Dunbrack, Roland L.
    Brennan, Timothy A.
    Andrake, Mark D.
    Zhou, Yan
    Serebriiskii, Ilya G.
    Slifker, Michael
    Alpaugh, Katherine
    Dulaimi, Essel
    Palma, Norma
    Hoffman-Censits, Jean
    Bilusic, Marijo
    Wong, Yu-Ning
    Kutikov, Alexander
    Viterbo, Rosalia
    Greenberg, Richard E.
    Chen, David Y. T.
    Lallas, Costas D.
    Trabulsi, Edouard J.
    Yelensky, Roman
    McConkey, David J.
    Miller, Vincent A.
    Golemis, Erica A.
    Ross, Eric A.
    EUROPEAN UROLOGY, 2015, 68 (06) : 959 - 967
  • [7] Platinum Concentration and Pathologic Response to Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
    Guancial, Elizabeth A.
    Kilari, Deepak
    Xiao, Guang-Qian
    Abu-Farsakh, Sohaib H.
    Baran, Andrea
    Messing, Edward M.
    Kim, Eric S.
    PLOS ONE, 2016, 11 (05):
  • [8] Cell-free DNA Methylation as a Predictive Biomarker of Response to Neoadjuvant Chemotherapy for Patients with Muscle-invasive Bladder Cancer in SWOG S1314
    Lu, Yi-Tsung
    Plets, Melissa
    Morrison, Gareth
    Cunha, Alexander T.
    Cen, Steven Y.
    Rhie, Suhn K.
    Siegmund, Kimberly D.
    Daneshmand, Siamak
    Quinn, David I.
    Meeks, Joshua J.
    Lerner, Seth P.
    Petrylak, Daniel P.
    Mcconkey, David
    Flaig, Thomas W.
    Thompson Jr, Ian M.
    Goldkorn, Amir
    EUROPEAN UROLOGY ONCOLOGY, 2023, 6 (05): : 516 - 524
  • [9] RNA Expression of DNA Damage Response Genes in Muscle-Invasive Bladder Cancer: Influence on Outcome and Response to Adjuvant Cisplatin-Based Chemotherapy
    Herrmann, Jonas
    Schmidt, Helena
    Nitschke, Katja
    Weis, Cleo-Aron
    Nuhn, Philipp
    von Hardenberg, Jost
    Michel, Maurice Stephan
    Erben, Philipp
    Worst, Thomas Stefan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (08)
  • [10] Alterations in DNA Damage Repair Genes Before and After Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer
    Lemberger, Ursula
    Ernhofer, Busra
    Krieger, Sigurd
    Bruchbacher, Andreas
    Oszwald, Andre
    Laukhtina, Ekaterina
    Haitl, Andrea
    Hassler, Melanie R.
    Englinger, Bernhard
    Shariat, Shahrokh F.
    EUROPEAN UROLOGY OPEN SCIENCE, 2025, 71 : 38 - 48
12345